- Raised $7.1M funding round led by Lightspeed Venture Partners, Jan 2025
- Raised funding round, Nov 2023
- Raised grant led by Israel Innovation Authority , Oct 2021
About
Senseera’s technology ushers a new generation of liquid biopsy blood tests providing unparalleled information about disease processes in the patient’s internal organs and immune system with a single blood test. Senseera’s mission is to transform disease diagnosis and treatment and to enhance development of new therapeutics.
The company uses molecular biology, next generation sequencing, and advanced computational analysis to extract rich epigenetic information encoded in chromatin fragments circulating in the blood and transform it into concrete clinical information.
Its cfChIP-seq technology uses the natural biological marking of chromatin to specifically enrich informative DNA fragments from active regions in the genome. Since the active part of the genome is relatively small we bypass the need for biased preselection of specific genes or markers. This unbiased approach increases the disease detection sensitivity and specificity and allows testing for many diseases for a significantly reduced cost, thus setting the stage for an extremely accurate and affordable human health screening.
Senseera first line of products is focused in developing an accurate, sensitive, and affordable blood test for early detection and monitoring of cancer. The company is also working closely with pharma companies to improve clinical trials monitoring, patients selection and evaluation of drug efficacy.
Funding history · 3 rounds · $7.1M total
Q&A
- What is Senseera Health's primary focus?
- Senseera Health is focused on developing a new generation of liquid biopsy blood tests to provide information about disease processes in internal organs and the immune system. Their initial product line aims for early detection and monitoring of cancer.
- When was Senseera Health founded?
- Senseera Health was founded in August 2020.
- How many employees does Senseera Health have?
- Senseera Health has between 11-50 employees.
- What is Senseera Health's total funding to date?
- Senseera Health has raised a total of $7,100,000.
- Which investors participated in Senseera Health's January 2025 funding round?
- In January 2025, Senseera Health raised $7,100,000 from investors including.
- What technology does Senseera Health utilize?
- Senseera Health uses molecular biology, next-generation sequencing, and advanced computational analysis to extract epigenetic information from chromatin fragments in the blood, employing its cfChIP-seq technology.
- Who are the co-founders of Senseera Health?
- The co-founders of Senseera Health are Ronen Sadeh (Co-founder & CEO), Nir Friedman (Co-founder), Jenia Gutin (Co-founder & CTO), and Israa Sharkia (Co-founder & VP R&D).
- What is the current product stage of Senseera Health?
- Senseera Health's product is currently in the clinical trial stage.
Team · 4
Sectors & technology
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | senseerahealth.com |
|---|---|
| linkedin.com/company/75502239 |
Identifiers & details
| Founded | 2020-8 |
|---|---|
| Employees (exact) | 19 |
Radar intelligence
Web history (Wayback)
| Domain | senseerahealth.com |
|---|
Certificate / subdomain footprint
| Subdomains | 8 |
|---|